Apparatus and Method for Delivery of Antimicrobial During a Transdermal Sampling and Delivery Process
Categories: “Medical and Research Devices“
Reference #: 2015-008
Connect with Industry
A minimally invasive transdermal device and method for delivering antimicrobial(s) to the exposed region of skin at the access point of interstitial fluid sampling, medical monitoring and/or transdermal drug delivery.
There is an ongoing need for mitigation of infection risks resulting from the use of minimally invasive medical devices. Various microorganisms and/or microbes may reside on the user’s skin and/or on the devices and can migrate through the interstitial fluid access location of such devices and cause infections. Some of these microorganisms include drug resistant bacteria, also called superbugs, which are increasingly resistant to known antibiotics.
- Mitigation of infection risks associated with the use of non-invasive and passive medical devices
- May be used to prevent infection from a variety of microorganisms and microbes
- Provides an all-in-one device for interstitial sampling, monitoring, drug-delivery and infection prevention
- Can be configured in the convenient form of an adhesive patch
Stage of Development
US Patent No. 11,219,390
Makarand Paranjape, PhD
Shruti M. Paranjape, PhD